Skip to main content

CHOLESTYRAMINE RESIN

Tracking # 20-841383

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

CHOLESTYRAMINE IS USED FOR THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA. THE REDUCTION IN LDL CHOLESTEROL BY THE RESIN IS DOSE-DEPENDENT. A DOSE OF 8 TO 12 GRAMS OF CHOLESTYRAMINE IS ASSOCIATED WITH 12% TO 18% REDUCTION IN LDL-CHOLESTEROL. IT ALSO REDUCES THE RISK OF CORONARY ARTERY DISEASE. CHOLESTYRAMINE CAN BE USED IN PATIENTS WITH BILE-ACID DIARRHEA OR CHOLERETIC ENTEROPATHY DUE TO LIMITED ILEAL DISEASE OR RESECTION. THIS ACTIVITY REVIEWS THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, TOXICITY, DOSING, PHARMACODYNAMICS, AND MONITORING OF CHOLESTYRAMINE THAT IS PERTINENT INFORMATION FOR MEMBERS OF THE INTERPROFESSIONAL TEAM WHEN LIPID LOWERING THERAPY IS INDICATED.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I